Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

Recruiting

Phase 1

Phase 2

Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

Sponsor:

Brigham and Women's Hospital

Code:

NCT04144257

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

[F-18]PBR06

[C-11]Methylreboxetine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-30. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2021-07-28.